Alora Pharmaceuticals Chief Commercial Officer, Shannon Faught Announced as a MM + M 2025 Woman of Distinction Honoree
Nyenta.com/10312517

ALPHARETTA, Ga., May 13, 2025 ~ In a recent announcement, Medical Marketing & Media (MM+M) has revealed the names of its 2025 Women of Distinction honorees. This prestigious program, now in its 10th year, recognizes and celebrates the achievements of female healthcare marketing executives who have made a significant impact on their organizations and the industry as a whole over the past year.

Among the honorees is Shannon Faught, Chief Commercial Officer for Alora Pharmaceuticals. In this role, Faught is responsible for driving commercial strategy and revenue growth for the organization. With over two decades of experience in the pharmaceutical industry, she brings a wealth of knowledge and expertise to her position.

Faught's key responsibilities include guiding products through promotion, launch preparation, and future commercialization. She has a strong focus on maximizing brand potential and driving launch excellence. Her leadership in sales, marketing, market access, operations, and omnichannel strategy has made her a standout leader in driving growth and innovation across the industry.

More on Nyenta.com

• MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
• ZEELOOL Show Stopper Glasses: Own the Holiday Spotlight
• The Best Cartier Love Bracelet Dupes to Shop Right Now
• From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
• Stunning Federal Irregularities Raise Alarms in High-Stakes Civil Rights Case Against NYS DEC

"Shannon is an exceptional leader whose strategic vision, integrity, and relentless focus on execution have made a lasting impact on Alora and the patients we serve," said Art Deas, Chief Executive Officer of Alora Pharmaceuticals. "She brings out the best in her team and leads with a rare combination of insight and empathy. I was proud to recognize her as the 2024 recipient of the Alora Excellence in Leadership Award and not surprised when I learned of her being honored as a 2025 MM&M Woman of Distinction."

Lecia Bushak, editor of pharma at MM+M, also commented on Faught's recognition: "Medical marketing stands out as an industry where women are leading the charge. For the 10th year in a row, we've been highlighting the extraordinary work of women who are driving creativity and innovation in the industry, as well as shaping the future of healthcare. We look forward to celebrating the accomplishments of the 2025 classes of Women of Distinction and Women to Watch."

The 2025 Women of Distinction honorees will be celebrated at an in-person event on June 3 in New York City. They will also be featured in the July-August print edition of MM+M. This recognition not only celebrates the achievements of these exceptional women but also serves as a reminder of the important role that women play in shaping the healthcare industry.

---

Show All News | Report Violation